Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Current Topics in Behavioral Neurosciences
|
November 25, 2010
Endocannabinoid receptor pharmacology
Betty Yao, Ken Mackie
Current Oncology (Toronto, Ont.)
|
May 26, 2023
Pediatric Brain Tumours: Lessons from the Immune Microenvironment
Betty Yao, Alberto Delaidelli, Hannes Vogel, et al.
Assay and Drug Development Technologies
|
September 26, 2012
Development and validation of a medium-throughput electrophysiological assay for KCNQ2/3 channel openers using QPatch HT
Xu-Feng Zhang, Di Zhang, Carol S Surowy, et al.
Nature Communications
|
September 28, 2013
Species differences and molecular determinant of TRPA1 cold sensitivity
Jun Chen, Dawon Kang, Jing Xu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 19, 2016
High antiviral activity of NS5A inhibitor ABT-530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection
Fred Poordad, Charles S Landis, Armen Asatryan, et al.
Current Drug Safety
|
March 20, 2012
Negative inotropic effect of a CB2 agonist A-955840 in isolated rabbit ventricular myocytes is independent of CB1 and CB2 receptors
Zhi Su, Lee Preusser, Gilbert Diaz, et al.
Antimicrobial Agents and Chemotherapy
|
December 30, 2015
Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection
Eric J Lawitz, William D O'Riordan, Armen Asatryan, et al.
Viruses
|
August 30, 2018
Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection
Teresa I Ng, Tami Pilot-Matias, Rakesh Tripathi, et al.
NPJ Precision Oncology
|
July 24, 2025
Molecular subtyping of endometrial carcinoma cell lines uncovers subtype-specific targetable vulnerabilities
Eunice S Li, Rebecca Ho, Ran Tao, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management
Derek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Current Topics in Behavioral Neurosciences
|
November 25, 2010
Endocannabinoid receptor pharmacology
Betty Yao, Ken Mackie
Current Oncology (Toronto, Ont.)
|
May 26, 2023
Pediatric Brain Tumours: Lessons from the Immune Microenvironment
Betty Yao, Alberto Delaidelli, Hannes Vogel, et al.
Assay and Drug Development Technologies
|
September 26, 2012
Development and validation of a medium-throughput electrophysiological assay for KCNQ2/3 channel openers using QPatch HT
Xu-Feng Zhang, Di Zhang, Carol S Surowy, et al.
Nature Communications
|
September 28, 2013
Species differences and molecular determinant of TRPA1 cold sensitivity
Jun Chen, Dawon Kang, Jing Xu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 19, 2016
High antiviral activity of NS5A inhibitor ABT-530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection
Fred Poordad, Charles S Landis, Armen Asatryan, et al.
Current Drug Safety
|
March 20, 2012
Negative inotropic effect of a CB2 agonist A-955840 in isolated rabbit ventricular myocytes is independent of CB1 and CB2 receptors
Zhi Su, Lee Preusser, Gilbert Diaz, et al.
Antimicrobial Agents and Chemotherapy
|
December 30, 2015
Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection
Eric J Lawitz, William D O'Riordan, Armen Asatryan, et al.
Viruses
|
August 30, 2018
Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection
Teresa I Ng, Tami Pilot-Matias, Rakesh Tripathi, et al.
NPJ Precision Oncology
|
July 24, 2025
Molecular subtyping of endometrial carcinoma cell lines uncovers subtype-specific targetable vulnerabilities
Eunice S Li, Rebecca Ho, Ran Tao, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management
Derek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
Page
of 1